公司简介

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

产品/服务

• 科技服务

third-generation antisense (3ga)

toll-like receptor immune modulation

融资信息

融资轮次	融资日期	投资方	融资额度
Series A	2010-01	Merck KGaA	$4.3M
Series B	2011-11	未披露	$9.5M
Post Ipo Equity	2014-02	未披露	$40M

关联公司